- Home
- Applications
- europe
- tumor activity
Show results for
Refine by
Tumor Activity Product Applications In Europe
3 applications found
We have developed proprietary methods for expressing immunotherapeutic payloads in a highly controlled and specific manner within tumors. IFN-α is a well-known therapeutic that was previously administered systemically for treatment of various cancers but it is currently rarely used because of its systemic toxicity. In the tumor microenvironment, IFN-α exerts its anti-tumor activity both directly by promoting cancer cell apoptosis and ...
ByGenenta Science based in Milano, ITALY
BOC Sciences is committed to supplying cost-effective products and services. We provide Hydroxysafflor yellow A (Cas No:78281-02-4). More information, please visit the website: http://www.bocsci.com/hydroxysafflor-yellow-a-cas-78281-02-4-item-474840.html ...
ByBOC Sciences based in Shirley, NEW YORK (USA)
Downregulating the immune response is necessary for the treatment of autoimmune diseases. In this aspect, the APO2L/TRAIL ligand is a key intermediate in immune cascades and is secreted in exosomes in natural conditions. Its alteration has been associated with rheumatoid arthritis. The administration of synthetic exosomes decorated with APO2L/TRAIL has been shown to be effective in reducing the hyperplasia and overall inflammation in this ...
ByNanovex Biotechnologies based in Llanera, SPAIN